Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Ginseng Res ; 47(6): 726-734, 2023 Nov.
Article in English | MEDLINE | ID: mdl-38107401

ABSTRACT

Background: Skeletal muscles play a key role in physical activity and energy metabolism. The loss of skeletal muscle mass can cause problems related to metabolism and physical activity. Studies are being conducted to prevent such diseases by increasing the mass and regeneration capacity of muscles. Ginsenoside Rg5 has been reported to exhibit a broad range of pharmacological activities. However, studies on the effects of Rg5 on muscle differentiation and growth are scarce. Methods: To investigate the effects of Rg5 on myogenesis, C2C12 myoblasts were induced to differentiate with Rg5, followed by immunoblotting, immunostaining, and qRT-PCR for myogenic markers and promyogenic signaling (p38MAPK). Immunoprecipitation confirmed that Rg5 increased the interaction between MyoD and E2A via p38MAPK. To investigate the effects of Rg5 on prevention of muscle mass loss, C2C12 myotubes were treated with dexamethasone to induce muscle atrophy. Immunoblotting, immunostaining, and qRT-PCR were performed for myogenic markers, Akt/mTOR signaling for protein synthesis, and atrophy-related genes (Atrogin-1 and MuRF1). Results: Rg5 promoted C2C12 myoblast differentiation through phosphorylation of p38MAPK and MyoD/E2A heterodimerization. Furthermore, Rg5 stimulated C2C12 myotube hypertrophy via phosphorylation of Akt/mTOR. Phosphorylation of Akt induces FoxO3a phosphorylation, which reduces the expression of Atrogin-1 and MuRF1. Conclusion: This study provides an understanding of how Rg5 promotes myogenesis and hypertrophy and prevents dexamethasone-induced muscle atrophy. The study is the first, to the best of our knowledge, to show that Rg5 promotes muscle regeneration and to suggest that Rg5 can be used for therapeutic intervention of muscle weakness and atrophy, including cancer cachexia.

2.
BMB Rep ; 55(9): 447-452, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35651331

ABSTRACT

Neurogenic differentiation 1 (NeuroD1) is an essential transcription factor for neuronal differentiation, maturation, and survival, and is associated with inflammation in lipopolysaccharide (LPS)- induced glial cells; however, the concrete mechanisms are still ambiguous. Therefore, we investigated whether NeuroD1-targeting miRNAs affect inflammation and neuronal apoptosis, as well as the underlying mechanism. First, we confirmed that miR-30a-5p and miR-153-3p, which target NeuroD1, reduced NeuroD1 expression in microglia and astrocytes. In LPS-induced microglia, miR-30a-5p and miR-153-3p suppressed pro-inflammatory cytokines, reactive oxygen species, the phosphorylation of c-Jun N-terminal kinase, extracellular-signal-regulated kinase (ERK), and p38, and the expression of cyclooxygenase and inducible nitric oxide synthase (iNOS) via the NF-κB pathway. Moreover, miR-30a-5p and miR-153-3p inhibited the expression of NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasomes, NLRP3, cleaved caspase-1, and IL-1ß, which are involved in the innate immune response. In LPS-induced astrocytes, miR-30a-5p and miR-153-3p reduced ERK phosphorylation and iNOS expression via the STAT-3 pathway. Notably, miR-30a-5p exerted greater anti-inflammatory effects than miR-153-3p. Together, these results indicate that miR-30a-5p and miR-153-3p inhibit MAPK/NF-κB pathway in microglia as well as ERK/STAT-3 pathway in astrocytes to reduce LPS-induced neuronal apoptosis. This study highlights the importance of NeuroD1 in microglia and astrocytes neuroinflammation and suggests that it can be regulated by miR-30a-5p and miR-153-3p. [BMB Reports 2022; 55(9): 447-452].


Subject(s)
Lipopolysaccharides , MicroRNAs , Anti-Inflammatory Agents , Apoptosis , Basic Helix-Loop-Helix Transcription Factors , Caspases/metabolism , Cytokines/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Inflammasomes/metabolism , Inflammation/genetics , Inflammation/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Lipopolysaccharides/pharmacology , MicroRNAs/genetics , MicroRNAs/metabolism , NF-kappa B/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Reactive Oxygen Species/metabolism
3.
Arch Pharm Res ; 44(9-10): 876-889, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34537916

ABSTRACT

Sarcopenia refers to the gradual loss of skeletal muscle mass and function along with aging and is a social burden due to growing healthcare cost associated with a super-aging society. Therefore, researchers have established guidelines and tests to diagnose sarcopenia. Several studies have been conducted actively to reveal the cause of sarcopenia and find an economic therapy to improve the quality of life in elderly individuals. Sarcopenia is caused by multiple factors such as reduced regenerative capacity, imbalance in protein turnover, alteration of fat and fibrotic composition in muscle, increased reactive oxygen species, dysfunction of mitochondria and increased inflammation. Based on these mechanisms, nonpharmacological and pharmacological strategies have been developed to prevent and treat sarcopenia. Although several studies are currently in progress, no treatment is available yet. This review presents the definition of sarcopenia and summarizes recent understanding on the detailed mechanisms, diagnostic criteria, and strategies for prevention and treatment.


Subject(s)
Histone Deacetylase Inhibitors/therapeutic use , Muscle Strength , Muscle, Skeletal/drug effects , Nutritional Support , Resistance Training , Sarcopenia/therapy , Animals , Antibodies, Monoclonal, Humanized , Functional Status , Humans , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Myostatin/antagonists & inhibitors , Myostatin/metabolism , Sarcopenia/diagnosis , Sarcopenia/metabolism , Sarcopenia/physiopathology , Treatment Outcome
4.
Int J Mol Sci ; 22(3)2021 Jan 26.
Article in English | MEDLINE | ID: mdl-33530496

ABSTRACT

S100 calcium-binding protein A8 (S100A8), a danger-associated molecular pattern, has emerged as an important mediator of the pro-inflammatory response. Some S100 proteins play a prominent role in neuroinflammatory disorders and increase the secretion of pro-inflammatory cytokines in microglial cells. The aim of this study was to determine whether S100A8 induced neuronal apoptosis during cerebral hypoxia and elucidate its mechanism of action. In this study, we reported that the S100A8 protein expression was increased in mouse neuronal and microglial cells when exposed to hypoxia, and induced neuroinflammation and neuronal apoptosis. S100A8, secreted from neurons under hypoxia, activated the secretion of tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) through phosphorylation of extracellular-signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in microglia. Also, phosphorylation of ERK via the TLR4 receptor induced the priming of the NLRP3 inflammasome. The changes in Cyclooxygenase-2 (COX-2) expression, a well-known inflammatory activator, were regulated by the S100A8 expression in microglial cells. Knockdown of S100A8 levels by using shRNA revealed that microglial S100A8 expression activated COX-2 expression, leading to neuronal apoptosis under hypoxia. These results suggested that S100A8 may be an important molecule for bidirectional microglia-neuron communication and a new therapeutic target for neurological disorders caused by microglial inflammation during hypoxia.


Subject(s)
Apoptosis/genetics , Calgranulin A/genetics , Gene Expression Regulation , Hypoxia/genetics , Hypoxia/metabolism , Microglia/metabolism , Neurons/metabolism , Animals , Biomarkers , Calgranulin A/metabolism , Cell Line , Cytokines/metabolism , Disease Susceptibility , Extracellular Signal-Regulated MAP Kinases/metabolism , Gene Knockdown Techniques , Inflammation/etiology , Inflammation/metabolism , Inflammation/pathology , Inflammation Mediators/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Mice , Phosphorylation
5.
BMB Rep ; 53(10): 527-532, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32635984

ABSTRACT

We recently reported that N-adamantyl-4-methylthiazol-2-amine (KHG26693) attenuates glutamate-induced oxidative stress and inflammation in the brain. In this study, we investigated KHG 26693 as a therapeutic agent against glutamate-induced autophagic death of cortical neurons. Treatment with KHG26693 alone did not affect the viability of cultured cortical neurons but was protective against glutamate-induced cytotoxicity in a concentration-dependent manner. KHG26693 attenuated the glutamate-induced increase in protein levels of LC3, beclin-1, and p62. Whereas glutamate decreased the phosphorylation of PI3K, Akt, and mTOR, these levels were restored by treatment with KHG26693. These results suggest that KHG26693 inhibits glutamate-induced autophagy by regulating PI3K/Akt/mTOR signaling. Finally, KHG26693 treatment also attenuated glutamateinduced increases in reactive oxygen species, glutathione, glutathione peroxidase, and superoxide dismutase levels in cortical neurons, indicating that KHG26693 also protects cortical neurons against glutamate-induced autophagy by regulating the reactive oxygen species scavenging system. [BMB Reports 2020; 53(10): 527-532].


Subject(s)
Adamantane/analogs & derivatives , Autophagy/drug effects , Neurons/metabolism , Thiazoles/pharmacology , Adamantane/metabolism , Adamantane/pharmacology , Animals , Antioxidants/pharmacology , Autophagic Cell Death , Autophagy/physiology , Cerebral Cortex/metabolism , Glutamic Acid/adverse effects , Glutamic Acid/metabolism , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Neurons/drug effects , Oxidative Stress/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Superoxide Dismutase/metabolism , TOR Serine-Threonine Kinases/metabolism , Thiazoles/metabolism
6.
Mater Sci Eng C Mater Biol Appl ; 104: 109983, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31499997

ABSTRACT

We report the development of halloysite nanotubes (HNTs)/carboxylated-cellulose nanocrystals (cCNCs) - reinforced and ionically-crosslinked k-carrageenan (k-CG)/xanthan gum (XG) hydrogels. In this study, cCNCs were extracted from microcrystalline cellulose using ammonium persulfate and exhibit 'spindle-like' nanocrystals with approximate diameter of 15-30 nm and length of 30-120 nm. The freeze-dried hydrogels showed highly porous microstructure with good pore-interconnectivity. Further, tunable swelling ratio and in vitro degradation rate of hydrogels under physiological condition (pH 7.4 PBS, 37 °C) were observed. In wet or dry states, the dynamic mechanical analysis of kCXGHN20cCN20 hydrogel showed significantly improved compressive strengths (at 50% strain: 8.1 ±â€¯1.35 kPa or 81.33 ±â€¯1.66 kPa, whereas at 70% strain: 11.84 ±â€¯0.61 kPa or 120.7 ±â€¯1.16 kPa) when reinforced with HNTs (20 wt%)/cCNCs (20 wt%), respectively. The stiffness values are reported at different compressive strains. All hydrogels showed excellent attachment and proliferation of human skin fibroblasts (CCD-986Sk) cells on hydrogels for 7 and 14 days of culture periods. The results showed that these hydrogels may have potential application in soft tissue engineering.


Subject(s)
Cellulose/chemistry , Clay/chemistry , Hydrogels/chemistry , Nanoparticles/chemistry , Nanotubes/chemistry , Polysaccharides/chemistry , Cell Line , Compressive Strength/drug effects , Fibroblasts/drug effects , Humans , Polysaccharides, Bacterial/chemistry , Porosity , Skin/drug effects , Tissue Engineering/methods
7.
Gut Pathog ; 10: 11, 2018.
Article in English | MEDLINE | ID: mdl-29556252

ABSTRACT

BACKGROUND: Malonate utilization, an important differential trait, well recognized as being possessed by six of the seven Cronobacter species is thought to be largely absent in Cronobacter sakazakii (Csak). The current study provides experimental evidence that confirms the presence of a malonate utilization operon in 24 strains of sequence type (ST) 64, obtained from Europe, Middle East, China, and USA; it offers explanations regarding the genomic diversity and phylogenetic relatedness among these strains, and that of other C. sakazakii strains. RESULTS: In this study, the presence of a malonate utilization operon in these strains was initially identified by DNA microarray analysis (MA) out of a pool of 347 strains obtained from various surveillance studies involving clinical, spices, milk powder sources and powdered infant formula production facilities in Ireland and Germany, and dried dairy powder manufacturing facilities in the USA. All ST64 C. sakazakii strains tested could utilize malonate. Zebrafish embryo infection studies showed that C. sakazakii ST64 strains are as virulent as other Cronobacter species. Parallel whole genome sequencing (WGS) and MA showed that the strains phylogenetically grouped as a separate clade among the Csak species cluster. Additionally, these strains possessed the Csak O:2 serotype. The nine-gene, ~ 7.7 kbp malonate utilization operon was located in these strains between two conserved flanking genes, gyrB and katG. Plasmidotyping results showed that these strains possessed the virulence plasmid pESA3, but in contrast to the USA ST64 Csak strains, ST64 Csak strains isolated from sources in Europe and the Middle East, did not possess the type six secretion system effector vgrG gene. CONCLUSIONS: Until this investigation, the presence of malonate-positive Csak strains, which are associated with foods and clinical cases, was under appreciated. If this trait was used solely to identify Cronobacter strains, many strains would likely be misidentified. Parallel WGS and MA were useful in characterizing the total genome content of these Csak O:2, ST64, malonate-positive strains and further provides an understanding of their phylogenetic relatedness among other virulent C. sakazakii strains.

8.
Genome Announc ; 5(8)2017 Feb 23.
Article in English | MEDLINE | ID: mdl-28232440

ABSTRACT

We introduce the draft genome sequences of five enterotoxigenic Bacillus cereus strains: Bc 12, Bc 67, Bc 111, Bc 112, and Bc 113, which were obtained from powdered infant formula. The genome sizes of the strains ranged from 5.5 to 5.8 Mb, and the G+C contents were ~35.2%.

9.
Mycobiology ; 43(4): 373-83, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26839496

ABSTRACT

Five halophytic plant species, Suaeda maritima, Limonium tetragonum, Suaeda australis, Phragmites australis, and Suaeda glauca Bunge, which are native to the Muan salt marsh of South Korea, were examined for fungal endophytes by sequencing the internal transcribed spacer (ITS) region containing ITS1, 5.8S rRNA, and ITS2. In total, 160 endophytic fungal strains were isolated and identified from the roots of the 5 plant species. Taxonomically, all 160 strains belonged to the phyla Ascomycota, Basidiomycota, and Zygomycota. The most dominant genus was Fusarium, followed by the genera Penicillium and Alternaria. Subsequently, using 5 statistical methods, the diversity indices of the endophytes were determined at genus level. Among these halophytic plants, P. australis was found to host the greatest diversity of endophytic fungi. Culture filtrates of endophytic fungi were treated to Waito-C rice seedlings for plant growth-promoting effects. The fungal strain Su-3-4-3 isolated from S. glauca Bunge provide the maximum plant length (20.1 cm) in comparison with wild-type Gibberella fujikuroi (19.6 cm). Consequently, chromatographic analysis of the culture filtrate of Su-3-4-3 showed the presence of physiologically active gibberellins, GA1 (0.465 ng/mL), GA3 (1.808 ng/mL) along with other physiologically inactive GA9 (0.054 ng/mL) and GA24 (0.044 ng/mL). The fungal isolate Su-3-4-3 was identified as Talaromyces pinophilus.

10.
J Nanosci Nanotechnol ; 14(12): 9165-8, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25971030

ABSTRACT

We demonstrate a simple and efficient method for separating metallic from semiconducting single-walled carbon nanotubes (SWNTs) using density-gradient ultracentrifugation. Density differences between metallic and semiconducting SWNTs, which enable SWNT separation by electronic type, are created using a single surfactant, i.e., sodium dodecyl sulfate (SDS), rather than a complex mixtures of surfactant, as is used in current separation schemes. SDS strongly adsorbs onto the surface of metallic SWNTs over semiconducting SWNTs by the mirror-charge phenomenon. Therefore, metallic SWNT-SDS assemblies have relatively smaller buoyant densities than semiconducting SWNT-SDS assemblies; thus, the metallic assemblies are easily collected at the most buoyant top fractions, whereas the semiconducting assemblies are collected at the bottom fractions. We also demonstrate that this protocol is valid regardless of the SWNT production method; that is, SWNTs grown by high-pressure carbon monoxide conversion (HiPco) and the arc discharge method. Optical absorption shows that the heavy bottom fractions consist of highly pure semiconducting nanotubes, whereas the buoyant top fractions consist of highly pure metallic nanotubes. In addition, films made of the separated metallic SWNTs exhibit lower sheet resistances than unsorted SWNTs by 53% for arc discharged and 64% for HiPco SWNTs, as expected.

11.
Nanoscale ; 5(15): 6773-8, 2013 Aug 07.
Article in English | MEDLINE | ID: mdl-23714851

ABSTRACT

Highly efficient exfoliation of individual single-walled carbon nanotubes (SWNTs) was successfully demonstrated by utilizing biocompatible phenoxylated dextran, a kind of polysaccharide, as a SWNT dispersion agent. Phenoxylated dextran shows greater ability in producing individual SWNTs from raw materials than any other dispersing agent, including anionic surfactants and another polysaccharide. Furthermore, with this novel polymer, SWNT bundles or impurities present in raw materials are removed under much milder processing conditions compared to those of ultra-centrifugation procedures. There exists an optimal composition of phenoxy groups (∼13.6 wt%) that leads to the production of high-quality SWNT suspensions, as confirmed by UV-vis-nIR absorption and nIR fluorescence spectroscopy. Furthermore, phenoxylated dextran strongly adsorbs onto SWNTs, enabling SWNT fluorescence even in solid-state films in which metallic SWNTs co-exist. By bypassing ultra-centrifugation, this low-energy dispersion scheme can potentially be scaled up to industrial production levels.


Subject(s)
Biocompatible Materials/chemistry , Dextrans/chemistry , Nanotubes, Carbon/chemistry , Nanotubes, Carbon/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...